Just to add some content: 23andme never did complete genomes, they only targeted specific markers. As a consumer product there really wasn't anything compelling, and it was too expensive.
They've now changed their business strategy from consumer to B2B and let go most of the consumer folks.
Because posting techcrunch articles is guaranteed karma ;)
> They've now changed their business strategy from consumer to B2B and let go most of the consumer folks.
So much for the 'me' part then.
Even if they didn't do 'whole genome' there might be a freezer there with the samples that they took in, so in the long run when whole genome analysis becomes cheap enough they might do a 'replay'.
They reserve the right to share your genetic data but at the same time they say they will not share your 'personal information' without your consent.
That's the weirdest thing I've ever seen in a privacy statement, for one it is contradictory (genetic data being rather personal), and on top of that it gets the priorities completely wrong.
The only good privacy policy for a company like this would be 'We guarantee that we destroy all information you have supplied us with after we send you your results, this includes any samples and personal data'.
Anything less simply won't do.